Loading...
XLONIUG
Market cap52mUSD
Dec 27, Last price  
12.70GBP
1D
-0.39%
1Q
23.90%
IPO
-77.91%
Name

Intelligent Ultrasound Group PLC

Chart & Performance

D1W1MN
XLON:IUG chart
P/E
P/S
371.91
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
27.97%
Rev. gr., 5y
16.03%
Revenues
11m
+10.62%
362,000731,0001,352,0001,804,1462,207,6333,286,1474,180,6305,313,1645,915,6715,170,0007,596,00010,100,00011,173,000
Net income
-3m
L-13.47%
-295,000-156,000-329,000-1,488,920-1,630,097-2,414,145-5,418,119-3,417,464-4,222,418-3,306,000-3,610,000-2,984,000-2,582,000
CFO
-2m
L+150.15%
-207,000-396,000167,000-1,405,534-950,768-2,187,494-2,195,656-2,591,779-3,293,202-2,260,000-1,819,000-684,000-1,711,000
Earnings
Apr 29, 2025

Profile

Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators and clinical ultrasound software in the United Kingdom, North America, and internationally. It provides ScanNav Assist, an AI-based ultrasound software products that provide real-time image analysis during protocol-based scanning in the women's health sector; ScanNav Anatomy Peripheral Nerve Block (PNB), an AI based ultrasound software, which can automatically identify and highlight key anatomical structures in a live ultrasound image; and ScanNav Detect, which facilitate the automatic recognition of abnormalities within a general medical ultrasound scan. The company also offers ScanNav HealthCheck, an ultrasound software products that aims to enable ultrasound scans to be performed at home; ScanTrainer, an educational tool that uses real patient scans and curriculum-based teaching across obstetrics, gynecology, general medicine, and emergency medicine; ScanNav Anatomy PNB Trainer to teach ultrasound-guided needling to medical professionals; BodyWorks Eve, an ultra-realistic female patient simulator designed for interactive?point of care ultrasound scenario training; and NeedleTrainer, an augmented reality needling for non-invasive, safe, and realistic ultrasound-guided needling training. In addition, it provides BabyWorks, a baby manikin training tool for point of care ultrasound and echocardiography in pediatric and neonatal care; HeartWorks, a highly realistic simulator with all the tools needed to learn echocardiography; BodyWorks, a hi-fidelity simulator used in critical care, intensive care, and emergency medicine; and ORSIM, a simulator designed to teach advanced bronchoscopy skills in a virtual environment. The company was formerly known as MedaPhor Group plc and changed its name to Intelligent Ultrasound Group plc in January 2019. Intelligent Ultrasound Group plc was founded in 2004 and is headquartered in Cardiff, the United Kingdom.
IPO date
Aug 27, 2014
Employees
65
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
11,173
10.62%
10,100
32.96%
7,596
46.92%
Cost of revenue
14,202
16,980
15,160
Unusual Expense (Income)
NOPBT
(3,029)
(6,880)
(7,564)
NOPBT Margin
Operating Taxes
(441)
(718)
(758)
Tax Rate
NOPAT
(2,588)
(6,162)
(6,806)
Net income
(2,582)
-13.47%
(2,984)
-17.34%
(3,610)
9.20%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,200
13
BB yield
-23.18%
-0.03%
Debt
Debt current
244
188
213
Long-term debt
1,136
784
1,127
Deferred revenue
272
209
320
Other long-term liabilities
65
65
65
Net debt
(1,712)
(6,255)
(3,671)
Cash flow
Cash from operating activities
(1,711)
(684)
(1,819)
CAPEX
(338)
(1,824)
(1,778)
Cash from investing activities
(2,121)
(1,823)
(1,777)
Cash from financing activities
(236)
4,548
(219)
FCF
(3,976)
(5,381)
(7,007)
Balance
Cash
3,031
7,166
4,950
Long term investments
61
61
61
Excess cash
2,533
6,722
4,631
Stockholders' equity
(20,471)
(24,582)
(22,778)
Invested Capital
31,234
37,108
33,373
ROIC
ROCE
EV
Common stock shares outstanding
326,870
275,274
269,965
Price
0.09
14.72%
0.08
-46.56%
0.15
5.17%
Market cap
30,562
36.23%
22,435
-45.51%
41,170
11.38%
EV
28,850
16,180
37,499
EBITDA
(1,414)
(5,496)
(6,376)
EV/EBITDA
Interest
29
31
37
Interest/NOPBT